Acute Exacerbations of COPD: Identification of Biological Clusters and Their Biomarkers.

Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., Lindblad, K., Patel, H., Rugman, P., Dodson, P., Jenkins, M., Saunders, M., Newbold, P., Green, R.H., Venge, P., Lomas, D.A., Barer, M.R., Johnston, S.L., Pavord, I.D., Brightling, C.E.
Journal   Am J Respir Crit Care Med.
Species  
Analytes Measured   Troponin I cardiac , Eotaxin-3 , GM-CSF , I-TAC , IL-10 , IL-13 , IL-4 , IL-5 , IL-6 , IL-6R , IL-8 , IP-10 , MCP-1 , MCP-4 , Myoglobin , RANTES , SAA , TARC , TNF-RI , TNF-RII
Matrix Tested   Serum and sputum
Year   2011
Volume  
Page Numbers  
Application   Cytokines and Chemokines
Abstract
Rationale Exacerbations of chronic obstructive pulmonary disease (COPD) are heterogeneous with respect to inflammation and etiology. Objectives Investigate biomarker expression in COPD exacerbations to identify biological clusters and determine biomarkers that recognise clinical COPD exacerbation phenotypes namely those associated with bacteria, viruses or eosinophilic airway inflammation. Methods Patients with COPD were observed for 1 year at stable and exacerbation visits. Biomarkers were measured in sputum and serum. Viruses and selected bacteria were assessed in sputum by polymerase chain reaction and routine diagnostic bacterial culture. Biological phenotypes were explored using unbiased cluster analysis and biomarkers that differentiated clinical exacerbation phenotypes were investigated. Measurements and Main Results 145 patients (101 men, 44 women) entered the study. 182 exacerbations were captured from 86 patients. Four distinct biological exacerbation clusters were identified. These were bacterial, viral or eosinophilic-predominant and a fourth was associated with limited changes in the inflammatory profile and was termed pauci-inflammatory. Of all exacerbations, 55%, 29% and 28% were associated with bacteria, virus and/or a sputum eosinophilia. The biomarkers that best identified these clinical phenotypes were sputum IL-1β (area under receiver-operator-characteristic-curve 0.89 (95% confidence interval 0.83 to 0.95), serum CXCL10 0.83 (0.70 to 0.96), and percentage peripheral eosinophils 0.85 (0.78 to 0.93) respectively. Conclusion The heterogeneity of the biological response of COPD exacerbations can be defined. Sputum IL-1β, serum CXCL10 and peripheral eosinophils are biomarkers of bacteria, virus or eosinophil associated exacerbations of COPD. Whether phenotype-specific biomarkers can be applied to direct therapy warrants further investigation.

View Publications

Related Products

V-PLEX Human TARC Gen. B Kit
TARC | Human
Singleplex
V-PLEX Human MCP-1 Gen. B Kit
MCP-1 | Human
Singleplex
V-PLEX Human IP-10 Gen. B Kit
IP-10 | Human
Singleplex
V-PLEX Human Eotaxin-3 Gen. B Kit
Eotaxin-3 | Human
Singleplex
V-PLEX Chemokine Panel 1 (human) Gen. B Kit
Eotaxin, Eotaxin-3, IP-10, MCP-1, MCP-4, MDC, MIP-1α, MIP-1β, TARC | Human
Multiplex
Human TARC Antibody
TARC | Human
Human MCP-4 Antibody
MCP-4 | Human
Human MCP-1 Antibody
MCP-1 | Human
Human IP-10 Antibody
IP-10 | Human
Human Eotaxin-3 Antibody
Eotaxin-3 | Human
V-PLEX Plus Human IP-10 Gen. B Kit
IP-10 | Human
Singleplex
V-PLEX NHP MCP-1 Gen. B Kit
MCP-1 | Non-human primate
Singleplex
V-PLEX NHP IP-10 Gen. B Kit
IP-10 | Non-human primate
Singleplex
V-PLEX Plus NHP MCP-1 Gen. B Kit
MCP-1 | Non-human primate
Singleplex
V-PLEX Plus NHP IP-10 Gen. B Kit
IP-10 | Non-human primate
Singleplex
V-PLEX Chemokine Panel 1 (NHP) Gen. B Kit
Eotaxin, Eotaxin-3, IP-10, MCP-1, MCP-4, MDC, MIP-1α, MIP-1β, TARC | Non-human primate
Multiplex
V-PLEX Plus Chemokine Panel 1 (NHP) Gen. B Kit
Eotaxin, Eotaxin-3, IP-10, MCP-1, MCP-4, MDC, MIP-1α, MIP-1β, TARC | Non-human primate
Multiplex
V-PLEX Plus Chemokine Panel 1 (human) Gen. B Kit
Eotaxin, Eotaxin-3, IP-10, MCP-1, MCP-4, MDC, MIP-1α, MIP-1β, TARC | Human
Multiplex
V-PLEX NHP TARC Gen. B Kit
TARC | Non-human primate
Singleplex
V-PLEX NHP MCP-4 Gen. B Kit
MCP-4 | Non-human primate
Singleplex
V-PLEX NHP Eotaxin-3 Gen. B Kit
Eotaxin-3 | Non-human primate
Singleplex
V-PLEX Human MCP-4 Gen. B Kit
MCP-4 | Human
Singleplex
V-PLEX Plus NHP TARC Gen. B Kit
TARC | Non-human primate
Singleplex
V-PLEX Plus NHP MCP-4 Gen. B Kit
MCP-4 | Non-human primate
Singleplex
V-PLEX Plus NHP Eotaxin-3 Gen. B Kit
Eotaxin-3 | Non-human primate
Singleplex
V-PLEX Plus Human TARC Gen. B Kit
TARC | Human
Singleplex
V-PLEX Plus Human MCP-4 Gen. B Kit
MCP-4 | Human
Singleplex
V-PLEX Plus Human MCP-1 Gen. B Kit
MCP-1 | Human
Singleplex
V-PLEX Plus Human Eotaxin-3 Gen. B Kit
Eotaxin-3 | Human
Singleplex
Chemokine Panel 1 (human) Gen. B Control Pack
Eotaxin, Eotaxin-3, IP-10, MCP-1, MCP-4, MDC, MIP-1α, MIP-1β, TARC | Human
R-PLEX Mouse I-TAC Assay
I-TAC | Mouse
Singleplex
R-PLEX Mouse I-TAC Antibody Set
I-TAC | Mouse
U-PLEX CAR-T Cell Safety Combo 1 (human)
GM-CSF, IFN-γ, IL-1β, IL-6, IL-10, MCP-1, TNF-α | Human
Multiplex
U-PLEX TBI Combo 1 (human)
CD40L (soluble), Fractalkine, IFN-γ, IL-1β, IL-6, IL-18, MCP-1, RANKL/TNFSF11, TNF-α, VEGF-D | Human
Multiplex
U-PLEX Multiple Sclerosis Combo 1 (human)
CTACK, Fractalkine, GRO-α, IL-7, IL-12/IL-23p40, IP-10, MCP-1, MIP-1β, MIP-3α | Human
Multiplex
U-PLEX Alzheimer's Disease Combo 1 (human)
Eotaxin, IL-1α, IL-12/IL-23p40, IL-16, IL-17A, MCP-1, MDC, MIF, SDF-1α, YKL-40 | Human
Multiplex
U-PLEX Human TNF-RII Assay
TNF-RII | Human
Singleplex
U-PLEX Human TNF-RII 384-well Assay
TNF-RII | Human
Singleplex
U-PLEX Human TNF-RI Assay
TNF-RI | Human
Singleplex
U-PLEX Human TNF-RI 384-well Assay
TNF-RI | Human
Singleplex
U-PLEX Human RANTES Assay
RANTES | Human
Singleplex
U-PLEX Human RANTES 384-well Assay
RANTES | Human
Singleplex
U-PLEX Human RANTES Antibody Set
RANTES | Human
U-PLEX Human TNF-RII Antibody Set
TNF-RII | Human
U-PLEX Human TNF-RI Antibody Set
TNF-RI | Human
U-PLEX CAR-T Cell Combo 2 (human)
GM-CSF, Granzyme A, Granzyme B, IFN-γ, IL-2, Perforin, TNF-α | Human
Multiplex
U-PLEX Long COVID Combo 1 (human)
IFN-β, IFN-γ, IL-6, Pentraxin 3 | Human
Multiplex
U-PLEX Oncolysis Combo 1 (human)
CTLA-4, IFN-α2a, IFN-β, IL-1β, IL-2Rα, IL-6, IL-8, IP-10, LAG3, MIP-1α, PD1 (epitope 1), TIGIT | Human
Multiplex
U-PLEX Macrophage M1 Combo 1 (mouse)
IL-1β, IL-6, IL-12p70, IL-15, IL-23, IP-10, MCP-1, MIP-1α, TNF-α | Mouse
Multiplex
U-PLEX Custom Biomarker Group 1 (mouse) 384-well Assays
Mouse
Multiplex
U-PLEX Mouse GM-CSF 384-Well Assay
GM-CSF | Mouse
Singleplex
U-PLEX Mouse IL-13 384-Well Assay
IL-13 | Mouse
Singleplex
U-PLEX Mouse IL-10 384-Well Assay
IL-10 | Mouse
Singleplex
U-PLEX Mouse IL-6 384-Well Assay
IL-6 | Mouse
Singleplex
U-PLEX Mouse IL-5 384-Well Assay
IL-5 | Mouse
Singleplex
U-PLEX Mouse IL-4 384-Well Assay
IL-4 | Mouse
Singleplex
U-PLEX Mouse MCP-1 384-Well Assay
MCP-1 | Mouse
Singleplex
U-PLEX Mouse IP-10 384-Well Assay
IP-10 | Mouse
Singleplex
U-PLEX Mouse TNF-RI 384-Well Assay
TNF-RI | Mouse
Singleplex
U-PLEX Mouse TARC 384-Well Assay
TARC | Mouse
Singleplex
U-PLEX Mouse RANTES 384-Well Assay
RANTES | Mouse
Singleplex
U-PLEX NHP IL-4 384-Well Assay
IL-4 | Non-human primate
Singleplex
U-PLEX NHP GM-CSF 384-Well Assay
GM-CSF | Non-human primate
Singleplex
U-PLEX NHP Eotaxin-3 384-Well Assay
Eotaxin-3 | Non-human primate
Singleplex
U-PLEX NHP IL-13 384-Well Assay
IL-13 | Non-human primate
Singleplex
U-PLEX NHP IL-10 384-Well Assay
IL-10 | Non-human primate
Singleplex
U-PLEX NHP IL-8 384-Well Assay
IL-8 | Non-human primate
Singleplex
U-PLEX NHP IL-6 384-Well Assay
IL-6 | Non-human primate
Singleplex
U-PLEX NHP IL-5 384-Well Assay
IL-5 | Non-human primate
Singleplex
U-PLEX NHP TARC 384-Well Assay
TARC | Non-human primate
Singleplex
U-PLEX NHP MCP-4 384-Well Assay
MCP-4 | Non-human primate
Singleplex
U-PLEX NHP MCP-1 384-Well Assay
MCP-1 | Non-human primate
Singleplex
U-PLEX NHP I-TAC 384-Well Assay
I-TAC | Non-human primate
Singleplex
U-PLEX NHP IP-10 384-Well Assay
IP-10 | Non-human primate
Singleplex
U-PLEX Custom Metabolic Group 1 (mouse) 384-well Assays
BAFF, BCA-1/BLC, BDNF, CD40/TNFRSF5, C-Peptide, Eotaxin, EPO, FGF-21, Ghrelin (active), Ghrelin (total), GLP-1 (active), GLP-1 (inactive), GLP-1 (total), Glucagon, GM-CSF, IFN-α, IFN-β, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12/IL-23p40, IL-12p70, IL-13, IL-15, IL-16, IL-17A, IL-17A/F, IL-17C, IL-17E/IL-25, IL-17F, IL-21, IL-22, IL-23, IL-27p28/IL-30, IL-31, IL-33, Insulin, IP-10, KC/GRO, Leptin, MCP-1, MCP-5/CCL12, MDC, MIP-1α, MIP-1β, MIP-2, MIP-3α, MMP-9 (total), PYY (total), RANTES, TARC, TNF-α, VEGF-A | Mouse
Multiplex
U-PLEX Biomarker Group 1 (NHP) 384-well Assays
CTACK, ENA-78, Eotaxin, Eotaxin-2, Eotaxin-3, FLT3L, Fractalkine, G-CSF, GM-CSF, GRO-α, I-309, IFN-α2a, IFN-γ, IL-1α, IL-1β, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12/IL-23p40, IL-12p70, IL-13, IL-15, IL-16, IL-17A, IL-17A/F, IL-17B, IL-17C, IL-17D, IL-17F, IL-18, IL-22, IL-23, IP-10, I-TAC, MCP-1, MCP-2, MCP-4, M-CSF, MDC, MIF, MIP-1α, MIP-1β, MIP-3α, MIP-3β, MIP-5, SDF-1α, TARC, TNF-α, TNF-β, TPO, TRAIL, VEGF-A, YKL-40 | Non-human primate
Multiplex
U-PLEX Custom Biomarker Group 3 (human) 384-well Assays
Human
Multiplex
U-PLEX Human SAA 384-Well Assay
SAA | Human
Singleplex
U-PLEX Custom Metabolic Group 1 (human) 384-well Assays
BAFF, BDNF, β-NGF, C-Peptide, CTACK, ENA-78, Eotaxin, Eotaxin-2, Eotaxin-3, EPO, FGF-21, FGF-23, FLT3L, Fractalkine, FSH, G-CSF, Ghrelin (active), Ghrelin (total), GIP (active), GIP (inactive), GIP (total), GLP-1 (active), GLP-1 (inactive), GLP-1 (total), Glucagon, GM-CSF, GRO-α, I-309, IFN-α2a, IFN-β, IFN-γ, IL-1α, IL-1β, IL-1RA, IL-2, IL-2Rα, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12/IL-23p40, IL-12p70, IL-13, IL-15, IL-16, IL-17A, IL-17A/F, IL-17C, IL-17D, IL-17E/IL-25, IL-17F, IL-18, IL-21, IL-22, IL-23, IL-27, IL-29/IFN-λ1, IL-31, IL-33, Insulin, IP-10, Leptin, Luteinizing Hormone (LH), MCP-1, MCP-2, MCP-4, M-CSF, MDC, MIF, MIP-1α, MIP-5, PP, Proinsulin, PYY (total), SDF-1α, TARC, TNF-α, TNF-β, TPO, TRAIL, TSLP, VEGF-A, YKL-40 | Human
Multiplex
U-PLEX Human GM-CSF 384-Well Assay
GM-CSF | Human
Singleplex
U-PLEX Human Eotaxin-3 384-Well Assay
Eotaxin-3 | Human
Singleplex
U-PLEX Human IL-13 384-Well Assay
IL-13 | Human
Singleplex
U-PLEX Human IL-10 384-Well Assay
IL-10 | Human
Singleplex
U-PLEX Human IL-8 384-Well Assay
IL-8 | Human
Singleplex
U-PLEX Human IL-6 384-Well Assay
IL-6 | Human
Singleplex
U-PLEX Human IL-5 384-Well Assay
IL-5 | Human
Singleplex
U-PLEX Human IL-4 384-Well Assay
IL-4 | Human
Singleplex
U-PLEX Human MCP-4 384-Well Assay
MCP-4 | Human
Singleplex
U-PLEX Human MCP-1 384-Well Assay
MCP-1 | Human
Singleplex
U-PLEX Human I-TAC 384-Well Assay
I-TAC | Human
Singleplex
U-PLEX Human IP-10 384-Well Assay
IP-10 | Human
Singleplex
U-PLEX Human TARC 384-Well Assay
TARC | Human
Singleplex
U-PLEX Custom Biomarker Group 1 (human) 384-well Assays
CTACK, ENA-78, Eotaxin, Eotaxin-2, Eotaxin-3, EPO, FLT3L, Fractalkine, G-CSF, GM-CSF, GRO-α, I-309, IFN-α2a, IFN-β, IFN-γ, IL-1α, IL-1β, IL-1RA, IL-2, IL-2Rα, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12/IL-23p40, IL-12p70, IL-13, IL-15, IL-16, IL-17A, IL-17A/F, IL-17B, IL-17C, IL-17D, IL-17E/IL-25, IL-17F, IL-18, IL-21, IL-22, IL-23, IL-27, IL-29/IFN-λ1, IL-31, IL-33, IP-10, I-TAC, MCP-1, MCP-2, MCP-3, MCP-4, M-CSF, MDC, MIF, MIP-1α, MIP-1β, MIP-3α, MIP-3β, MIP-5, SDF-1α, TARC, TNF-α, TNF-β, TPO, TRAIL, TSLP, VEGF-A, YKL-40 | Human
Multiplex
Human MCP-4 Antibody
MCP-4 | Human
U-PLEX Custom Biomarker Group 3 (human) Assays
Human
Multiplex
U-PLEX Human SAA Antibody Set
SAA | Human
U-PLEX Vascular Injury Combo 1 (human)
CRP, Factor VII, ICAM-1, SAA, VCAM-1 | Human
Multiplex
U-PLEX Inflammation Combo 1 (human)
Complement C9, Complement factor D, CRP, ICAM-1, NGAL/LCN2, SAA, VCAM-1 | Human
Multiplex
U-PLEX Human SAA Assay
SAA | Human
Singleplex
S-PLEX Proinflammatory Panel 1 (human) Kit
IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-10, IL-12p70, IL-17A, TNF-α | Human
Multiplex
Product Search
Browse Our Products

By Analytes
By Applications
Search
Customer Service/Orders


Scientific/Technical Support


Instrument Support


Company Headquarters